Edwards Lifesciences
739 hedge funds and large institutions have $19.3B invested in Edwards Lifesciences in 2017 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 270 increasing their positions, 258 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $20.8B → $19.3B (-$1.52B)
28% less call options, than puts
Call options by funds: $79.4M | Put options by funds: $111M
29% less funds holding in top 10
Funds holding in top 10: 14 → 10 (-4)
Holders
739
Holding in Top 10
10
Calls
$79.4M
Puts
$111M
Top Buyers
| 1 | +$147M | |
| 2 | +$106M | |
| 3 | +$88M | |
| 4 |
NSLI
Nan Shan Life Insurance
Taipei City,
Taiwan
|
+$66.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$62.3M |
Top Sellers
| 1 | -$107M | |
| 2 | -$94.2M | |
| 3 | -$79.4M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$65.6M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$65.3M |